Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy
Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy
About this item
Full title
Author / Creator
Publisher
United States: Elsevier B.V
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier B.V
Subjects
More information
Scope and Contents
Contents
CUB-domain-containing-protein-1 (CDCP1) is an integral membrane protein whose expression is up-regulated in various cancer types. Although high CDCP1 expression has been correlated with poor prognosis in lung, breast, pancreas, and renal cancer, its functional role in tumor formation or progression is incompletely understood. So far it has remained...
Alternative Titles
Full title
Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5528444
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5528444
Other Identifiers
ISSN
1574-7891
E-ISSN
1878-0261
DOI
10.1016/j.molonc.2013.08.009
